PE20061051A1 - Composicion farmaceutica que comprende mirtazapina s - Google Patents
Composicion farmaceutica que comprende mirtazapina sInfo
- Publication number
- PE20061051A1 PE20061051A1 PE2005001334A PE2005001334A PE20061051A1 PE 20061051 A1 PE20061051 A1 PE 20061051A1 PE 2005001334 A PE2005001334 A PE 2005001334A PE 2005001334 A PE2005001334 A PE 2005001334A PE 20061051 A1 PE20061051 A1 PE 20061051A1
- Authority
- PE
- Peru
- Prior art keywords
- pharmaceutical composition
- composition including
- mirtazapine
- refers
- including mirtazapine
- Prior art date
Links
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001785 mirtazapine Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04105778 | 2004-11-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061051A1 true PE20061051A1 (es) | 2006-10-26 |
Family
ID=34929859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005001334A PE20061051A1 (es) | 2004-11-15 | 2005-11-14 | Composicion farmaceutica que comprende mirtazapina s |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US20070265245A1 (enExample) |
| EP (1) | EP1814555B1 (enExample) |
| JP (1) | JP2008519810A (enExample) |
| KR (1) | KR20070085470A (enExample) |
| CN (2) | CN101056641A (enExample) |
| AR (1) | AR053780A1 (enExample) |
| AT (1) | ATE439843T1 (enExample) |
| AU (1) | AU2005303778B2 (enExample) |
| BR (1) | BRPI0517818A2 (enExample) |
| CA (1) | CA2587283C (enExample) |
| CY (1) | CY1110538T1 (enExample) |
| DE (1) | DE602005016141D1 (enExample) |
| DK (1) | DK1814555T3 (enExample) |
| ES (1) | ES2329815T3 (enExample) |
| HR (1) | HRP20090513T1 (enExample) |
| IL (1) | IL182767A (enExample) |
| MX (1) | MX2007005827A (enExample) |
| MY (1) | MY144089A (enExample) |
| NO (1) | NO20072285L (enExample) |
| NZ (1) | NZ554858A (enExample) |
| PE (1) | PE20061051A1 (enExample) |
| PL (1) | PL1814555T3 (enExample) |
| PT (1) | PT1814555E (enExample) |
| RS (1) | RS51138B (enExample) |
| RU (1) | RU2396957C2 (enExample) |
| SI (1) | SI1814555T1 (enExample) |
| TW (1) | TW200631584A (enExample) |
| UA (1) | UA88655C2 (enExample) |
| WO (1) | WO2006051111A1 (enExample) |
| ZA (1) | ZA200703884B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007002174A2 (en) * | 2005-06-27 | 2007-01-04 | N.V. Organon. | A method of treatment of hormone depletion induced vasomotor symptoms |
| US20070129611A1 (en) * | 2005-12-06 | 2007-06-07 | University Of North Texas Health Science Center At Fort Worth | System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms |
| EP1993556A1 (en) * | 2006-03-06 | 2008-11-26 | N.V. Organon | An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms |
| AU2007324467A1 (en) * | 2006-11-22 | 2008-05-29 | N.V. Organon | Vaginal delivery system for mirtazapine |
| US7645750B2 (en) * | 2006-12-13 | 2010-01-12 | Yung Shin Pharmaceutical Ind. Co., Ltd. | Method of treating symptoms of hormonal variations |
| JP2009018992A (ja) | 2007-07-10 | 2009-01-29 | Sumitomo Chemical Co Ltd | 光学活性ミルタザピンの製造方法 |
| US8420624B2 (en) | 2007-12-04 | 2013-04-16 | Yung Shin Pharm. Ind. Co., Ltd. | Methods for treating or preventing symptoms of hormonal variations |
| JP6876003B2 (ja) | 2015-02-27 | 2021-05-26 | デクラ リミテッド | イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置 |
| KR102608479B1 (ko) * | 2017-05-25 | 2023-12-01 | 글리테크 엘엘씨. | Nmdar 길항제-반응성 신경정신 질환을 위한 병용 요법 |
| WO2021167579A1 (ru) | 2020-02-19 | 2021-08-26 | Иван УЛИНИЧ | Универсальное устройство для тепловой обработки пищевых продуктов |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| US4515792A (en) * | 1982-09-30 | 1985-05-07 | Ciba-Geigy Corporation | Tetracyclic heterocycles and antidepressant compositions thereof |
| JPH1187727A (ja) * | 1997-09-12 | 1999-03-30 | Mitsubishi Electric Corp | 半導体装置 |
| ES2212550T3 (es) * | 1998-04-02 | 2004-07-16 | Akzo Nobel N.V. | Solucion oral liquida que comprende el antidepresor mirtazapina. |
| RU2195951C1 (ru) * | 2001-08-20 | 2003-01-10 | Общество с ограниченной ответственностью "Лаборатория "Ирис" | Средство для лечения климактерических расстройств |
-
2005
- 2005-11-10 TW TW094139442A patent/TW200631584A/zh unknown
- 2005-11-14 PE PE2005001334A patent/PE20061051A1/es not_active Application Discontinuation
- 2005-11-14 EP EP05808013A patent/EP1814555B1/en not_active Expired - Lifetime
- 2005-11-14 PL PL05808013T patent/PL1814555T3/pl unknown
- 2005-11-14 RS RSP-2009/0504A patent/RS51138B/sr unknown
- 2005-11-14 BR BRPI0517818-5A patent/BRPI0517818A2/pt not_active IP Right Cessation
- 2005-11-14 AR ARP050104768A patent/AR053780A1/es unknown
- 2005-11-14 JP JP2007540655A patent/JP2008519810A/ja active Pending
- 2005-11-14 PT PT05808013T patent/PT1814555E/pt unknown
- 2005-11-14 AU AU2005303778A patent/AU2005303778B2/en not_active Expired
- 2005-11-14 DK DK05808013T patent/DK1814555T3/da active
- 2005-11-14 AT AT05808013T patent/ATE439843T1/de active
- 2005-11-14 WO PCT/EP2005/055947 patent/WO2006051111A1/en not_active Ceased
- 2005-11-14 KR KR1020077011981A patent/KR20070085470A/ko not_active Ceased
- 2005-11-14 CN CNA200580038949XA patent/CN101056641A/zh active Pending
- 2005-11-14 CN CN2012102639294A patent/CN102772414A/zh active Pending
- 2005-11-14 MY MYPI20055321A patent/MY144089A/en unknown
- 2005-11-14 CA CA2587283A patent/CA2587283C/en not_active Expired - Fee Related
- 2005-11-14 MX MX2007005827A patent/MX2007005827A/es active IP Right Grant
- 2005-11-14 DE DE602005016141T patent/DE602005016141D1/de not_active Expired - Lifetime
- 2005-11-14 RU RU2007122391/14A patent/RU2396957C2/ru not_active IP Right Cessation
- 2005-11-14 UA UAA200705135A patent/UA88655C2/ru unknown
- 2005-11-14 NZ NZ554858A patent/NZ554858A/en not_active IP Right Cessation
- 2005-11-14 ES ES05808013T patent/ES2329815T3/es not_active Expired - Lifetime
- 2005-11-14 SI SI200530802T patent/SI1814555T1/sl unknown
- 2005-11-14 HR HR20090513T patent/HRP20090513T1/xx unknown
- 2005-11-14 US US11/667,579 patent/US20070265245A1/en not_active Abandoned
-
2007
- 2007-04-23 IL IL182767A patent/IL182767A/en not_active IP Right Cessation
- 2007-04-30 NO NO20072285A patent/NO20072285L/no not_active Application Discontinuation
- 2007-05-14 ZA ZA200703884A patent/ZA200703884B/xx unknown
-
2009
- 2009-10-12 CY CY20091101044T patent/CY1110538T1/el unknown
-
2010
- 2010-07-01 US US12/828,720 patent/US20100267694A1/en not_active Abandoned
-
2012
- 2012-08-09 US US13/570,481 patent/US20120302552A1/en not_active Abandoned
-
2013
- 2013-04-05 US US13/857,445 patent/US20130225559A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200626068A (en) | Active compounds for seed treatment | |
| MY145439A (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
| CL2018001677A1 (es) | Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert | |
| MY157661A (en) | Bendamustine pharmaceutical compositions | |
| EP2400847A4 (en) | SPECIFIC DIARYLHYDANTOIN AND DIARYLTHIOHYDANTOINE COMPOUNDS | |
| CY1115725T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων | |
| GEP20115293B (en) | Isolated extract of walnuts, process for its obtaining and its use | |
| PL2244703T3 (pl) | Lekarstwo, jego wytwarzanie i zastosowanie w leczeniu bolesnych neuropatii | |
| SE0300098D0 (sv) | Use of cyclin D1 inhibitors | |
| NZ595364A (en) | TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC beta-CELL DYSFUNCTION | |
| SI1853232T1 (sl) | Stabilna kristalna oblika bifeprunoks-mezilata, njegove dozirne oblike in postopki za njihovo uporabo | |
| ATE541567T1 (de) | Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten | |
| CL2008003780A1 (es) | Compuestos derivados de azetidinas; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso para el tratamiento o la prevencion de trastornos psiquiatricos, dependencia o deshabituacion a una sustancia, trastornos cognitivos, enfermedades neurodegenerativas, entre otras. | |
| RU2007122391A (ru) | S-миртазапин для лечения приливов | |
| MX2007004259A (es) | Uso de compuestos organicos. | |
| TWI264307B (en) | Pharmaceutical composition containing bakuchiol for treating woman breast cancer | |
| RU2008107113A (ru) | Средство и способ профилактики и лечения пациентов с болезнью альцгеймера | |
| UA33293U (ru) | Способ лечения хронического эндометрита | |
| ATE411014T1 (de) | Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblichem brustkrebs | |
| ATE493976T1 (de) | Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose | |
| MD2827G2 (ro) | Metodă de profilaxie a hiperplaziilor dishormonale ale glandei mamare | |
| BRPI0419032B8 (pt) | composição farmacêutica de liberação prolongada de hidralazina | |
| MD3446F1 (en) | Method of HIV infection treatment | |
| DE602006002126D1 (de) | Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativa | |
| UA96278C2 (ru) | Применение флибансерина для лечения расстройств полового влечения в предклимактерический период |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |